ACCESS REALMONEY
Email This Article
Headlines & Perspectives
Immunex Offers Data That Enbrel Has Broader Potential
By
Adam Feuerstein
11/12/01 - 11:12 AM EST
Revenue could double from the rheumatoid arthritis drug if the FDA approves its wider use.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
Sign up for our FREE newsletters now.
Keep on top of the market and the critical information you need to make more profitable investing decisions.
